Main Article Content
Background: Acute respiratory distress syndrome (ARDS) remains one among the most reasons for ICU admission. It is related to high rates of mortality despite many recent advances in overall support. A relative increase in oxidative stress in patients with ARDS results in increased alveolar injury. Immunonutrion containing omega 3 fatty acids is one among the strategies that currently receiving attention within the management of ARDS since they are known to have anti-inflammatory effects, but the results are still inconsistent.
Objective: This study aimed to find out the efficacy of immunonutrition containing omega 3 fatty acids in reducing mortality in patients with ARDS.
Methodology: Electronic literature researches were performed in PubMed, Cochrane, and Scopus. MeSH term and title/abstracts were screened based on inclusion and exclusion criteria before relevant journals were reviewed.
Results: Two articles were selected based on the eligibility criteria and relevance to the clinical questions. The study of Langlois P. et al. found significantly reduced mortality in patients receiving continuous enteral infusion route of immunonutrition containing omega 3 fatty acids. While Dushianthan A. et al. found little or no mortality benefit with the administration of immunonutrition containing omega 3 fatty acids.
Conclusions: There is little or no mortality reduction within the administration of immunonutrition containing omega 3 fatty acids.
Keywords: acute respiratory distress syndrome, ARDS, immunonutrition, omega 3 fatty acids, mortality.
This journal provides direct open access to its content on the principle that making research freely available to the public supports greater global knowledge exchange. IJCNP Journal offers all journal article writers to have their research openly available, free access and time-limited.
All articles published in Open Access will be immediately and permanently free for everyone, where the articles can be read and downloaded. With alicense CC BY-SA,
Authors retain copyright to their articles, but authors allow others to use the published content in whole or in part as long as the original work is cited properly. Users (redistributors) of IJCNP are asked to cite the original source, including the name of the author, IJCNP as the source of initial publication, year of publication, number and volume.
Copyright includes the exclusive right to reproduce and transmit this article in all forms and media, including reprints, photographs, microfilm and other similar reproductions, and translations thereof. Reproduction of any part of this journal, its database storage and transmission in any form or medium, such as electronic, electrostatic and mechanical copies, photocopying, recording, magnetic media.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.